Real Time Imaging Technologies, LLC Secures New Patent

Real Time Imaging Technologies LLC is pleased to announce that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the Company’s methods for incorporating microlens into x-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.

“The microlens significance rests on its capacity to efficiently collect and focus the low radiation low light that would have otherwise fallen onto the non-sensitive areas of the collector and thereby increasing detector’s fill factor and quantum efficiency.

This will translate into more sensitive x-ray detectors for low-dose imaging acquisition and a pixel size reduction for an increased spatial resolution and diagnostic confidence, said Dr. Uzbelger Feldman, the inventor of this breakthrough for medical, dental, and veterinary x-rays imaging detection.

“Today’s announcement broadens our current expansive patent portfolio covering important diagnostic and procedural imaging technology. Our technology is designed to assist physicians, dentists and vets to be able to visualize and navigate procedures more safely and efficiently with significantly less radiation dose exposure,” said Michael Sinsheimer, Chairman and Co-founder of Real Time Imaging Technologies, LLC.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”